Page last updated: 2024-10-23

bisbenzimidazole and Sarcoma, Ewing

bisbenzimidazole has been researched along with Sarcoma, Ewing in 2 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Sarcoma, Ewing: A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Werner, S1
Mendoza, A1
Hilger, RA1
Erlacher, M1
Reichardt, W1
Lissat, A1
Konanz, C1
Uhl, M1
Niemeyer, CM1
Khanna, C1
Kontny, U1
Boschman, GA1
Rens, W1
Manders, EM1
Slater, RM1
Versteeg, R1
Aten, JA1

Other Studies

2 other studies available for bisbenzimidazole and Sarcoma, Ewing

ArticleYear
Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma.
    Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:1

    Topics: Animals; Annexin A5; Antineoplastic Agents, Alkylating; Apoptosis; Bisbenzimidazole; Blotting, Weste

2008
Detection of recurrent chromosome abnormalities in Ewing's sarcoma and peripheral neuroectodermal tumor cells using bivariate flow karyotyping.
    Genes, chromosomes & cancer, 1992, Volume: 5, Issue:4

    Topics: Bisbenzimidazole; Bone Neoplasms; Chromomycin A3; Chromosome Aberrations; Chromosomes, Human, Pair 1

1992